Pure Global

System Accuracy of BGM GL22 - Trial NCT06146933

Access comprehensive clinical trial information for NCT06146933 through Pure Global AI's free database. This phase not specified trial is sponsored by Institut fur Diabetes Karlsburg GmbH and is currently Completed. The study focuses on Diabetes. Target enrollment is 113 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06146933
Completed
diagnostic test
Trial Details
ClinicalTrials.gov • NCT06146933
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
System Accuracy of BGM GL22
Evaluierung Der Systemgenauigkeit Des Blutglucosemonitoring Systems GL22 gemäß DIN EN ISO 15197:2015.

Study Focus

Diabetes

Glucometer Test

Interventional

diagnostic test

Sponsor & Location

Institut fur Diabetes Karlsburg GmbH

Karlsburg, Germany

Timeline & Enrollment

N/A

Nov 01, 2023

Nov 24, 2023

113 participants

Primary Outcome

Analysis of system accuracy based on DIN EN ISO 15197

Summary

This study assesses the system accuracy of a blood glucose monitoring system pursuant to ISO
 15197

ICD-10 Classifications

Diabetes mellitus
Unspecified diabetes mellitus
Other specified diabetes mellitus
Unspecified diabetes mellitus without complications
Other specified diabetes mellitus without complications

Data Source

ClinicalTrials.gov

NCT06146933

Non-Device Trial